Fri, 19 Apr 2024


Dr Barde becomes first pharmacist secretary of NASS, PSN congratulates him
By: News Editor
Sat, 19 Nov 2022   ||   Nigeria, Abuja

History has been made in the Pharmacy profession as Dr Ali Barde Umoru has been appointed Acting Secretary, Research and Information of the National Assembly (NASS), making him the first pharmacist to assume the position.
The Abuja branch of the Pharmaceutical Society of Nigeria (PSN) has expressed her profound joy over the feat, while congratulating Dr Barde, who was formerly the Director of Pharmacy of the NASS.
In an exclusive statement sent to CEOAFRICA and signed by the vice chairman of the branch, Dr Abubakar Danraka, on behalf of the Chairman, the Executive Committee and the entire members of Abuja branch of the PSN, the branch is happy to felicitate with the new Honourable Secretary, National Assembly.
"Congratulations to our own Pharm. (Dr) Ali Barde Umoru, who was until now, the Director, Pharmaceutical Services at the National Assembly, now appointed Secretary, Research and Information of the National Assembly. Hon. Secretary at the National Assembly is equivalent to Permanent Secretary at the Federal Civil Service.
"History is made as Ali becomes the first pharmacist to attain that position at the National Assembly. Congratulations once again, Sir," the statement reads.
Meanwhile, the National Assembly Service Commission (NASC) had earlier announced the appointment of an Acting Clerk of the National Assembly (CNA), together with other six principal officers, to man the assembly, as contained in a press statement signed by the Executive Chairman of the commission, Engr Ahmed Kadi Amshi.
The newly appointed Acting CNA is Mr Sani Magaji Tambuwal, who was before now, the Secretary, Finance and Accounts of the NASS.
The outgoing CNA, Arc. Ojo Olatunde Amos, has been mandated to work with the Acting CNA, till his retirement in February 2023, to ensure the success of the 2023 Appropriation Bill’s processing, which can only be transmitted by a substantive clerk.


Back to News